We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Strategic Pricing Shield Monster Beverage From Rising Costs?
Read MoreHide Full Article
Key Takeaways
Monster Beverage Q3 gross margin rose to 55.7% from 53.2% on pricing actions and favorable mix.
Monster Beverage implemented U.S. price increases and lower promotions to manage rising input costs.
Monster Beverage saw profit growth outpace sales as pricing discipline and efficiencies boosted leverage.
Monster Beverage Corporation (MNST - Free Report) is leveraging disciplined pricing actions and supply chain efficiencies to protect margins amid rising input costs. In the third quarter of 2025, gross margin expanded to 55.7% from 53.2% a year earlier, supported by pricing initiatives and a favorable product mix that helped offset higher aluminium can costs and increased promotional spending.
Management acknowledged that cost pressures remain, particularly from higher aluminum costs, driven by tariff-related increases in the Midwest premium. While tariffs had only a modest impact in the third quarter, Monster Beverage expects some continued pressure into the fourth quarter of 2025 and early 2026.
To counter these headwinds, Monster Beverage implemented U.S. pricing changes effective from Nov. 1, 2025, including frontline price increases and reduced promotional allowances by package and channel. The company’s pricing framework incorporates consumer purchasing patterns, brand strength, channel dynamics and packaging mix to optimize revenue, while maintaining demand.
Monster Beverage’s pricing strategy is not a blunt, across-the-board increase. Management emphasized a disciplined revenue growth management framework that balances rate, trade spend, package mix and channel mix, while closely monitoring consumer elasticity. The company expects minimal volume impact from these actions, citing the energy drink category’s strong value proposition and the relatively modest pace of price increases compared with other non-alcoholic beverages. This pricing discipline is further supported by robust category growth and strong brand momentum, particularly within the Ultra family and zero-sugar offerings, which also benefit margins through a favorable mix. Combined with ongoing supply chain investments and optimization efforts, Monster Beverage’s strategic pricing appears well-positioned to absorb rising input costs while sustaining profitability. Overall, while cost inflation remains a risk, Monster Beverage’s measured and data-driven pricing strategy should help shield margins and support earnings growth in the periods ahead.
The Zacks Rundown for MNST
In the past six-month period, MNST’s shares have gained 38.8% compared with the industry’s growth of 11.9%. MNST presently carries a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
From a valuation standpoint, MNST trades at a forward price-to-earnings ratio of 33.86X, higher than the industry’s average of 18.20X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MNST’s current and next year earnings implies a year-over-year rise of 22.8% and 15.2%, respectively.
Image Source: Zacks Investment Research
Top-Ranked Stocks to Consider
The Simply Good Foods Company (SMPL - Free Report) , a consumer-packaged food and beverage company, engages in the development, marketing, and sale of snacks and meal replacements, and other products in North America and internationally. SMPL currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Simply Good Foods' current fiscal-year sales implies a decline of 0.3%, and the same for current fiscal-year earnings implies growth of 1.6% from the year-ago reported figures. SMPL delivered a trailing four-quarter earnings surprise of 5.53%, on average.
Kimberly-Clark Corporation (KMB - Free Report) manufactures and markets personal care products in the United States. KMB currently carries a Zacks Rank #1.
The Zacks Consensus Estimate for Kimberly-Clark's current fiscal-year sales and earnings implies a decline of 2.1% and 6.2%, respectively, from the year-ago actuals. KMB delivered a trailing four-quarter earnings surprise of 18.9%, on average.
Medifast, Inc. (MED - Free Report) operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. MED currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for Medifast's current fiscal-year sales and earnings implies a decline of 36.7% and 156.5%, respectively, from the year-ago actuals. MED delivered a trailing four-quarter negative earnings surprise of 640%, on average.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Will Strategic Pricing Shield Monster Beverage From Rising Costs?
Key Takeaways
Monster Beverage Corporation (MNST - Free Report) is leveraging disciplined pricing actions and supply chain efficiencies to protect margins amid rising input costs. In the third quarter of 2025, gross margin expanded to 55.7% from 53.2% a year earlier, supported by pricing initiatives and a favorable product mix that helped offset higher aluminium can costs and increased promotional spending.
Management acknowledged that cost pressures remain, particularly from higher aluminum costs, driven by tariff-related increases in the Midwest premium. While tariffs had only a modest impact in the third quarter, Monster Beverage expects some continued pressure into the fourth quarter of 2025 and early 2026.
To counter these headwinds, Monster Beverage implemented U.S. pricing changes effective from Nov. 1, 2025, including frontline price increases and reduced promotional allowances by package and channel. The company’s pricing framework incorporates consumer purchasing patterns, brand strength, channel dynamics and packaging mix to optimize revenue, while maintaining demand.
Monster Beverage’s pricing strategy is not a blunt, across-the-board increase. Management emphasized a disciplined revenue growth management framework that balances rate, trade spend, package mix and channel mix, while closely monitoring consumer elasticity. The company expects minimal volume impact from these actions, citing the energy drink category’s strong value proposition and the relatively modest pace of price increases compared with other non-alcoholic beverages.
This pricing discipline is further supported by robust category growth and strong brand momentum, particularly within the Ultra family and zero-sugar offerings, which also benefit margins through a favorable mix. Combined with ongoing supply chain investments and optimization efforts, Monster Beverage’s strategic pricing appears well-positioned to absorb rising input costs while sustaining profitability. Overall, while cost inflation remains a risk, Monster Beverage’s measured and data-driven pricing strategy should help shield margins and support earnings growth in the periods ahead.
The Zacks Rundown for MNST
In the past six-month period, MNST’s shares have gained 38.8% compared with the industry’s growth of 11.9%. MNST presently carries a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
From a valuation standpoint, MNST trades at a forward price-to-earnings ratio of 33.86X, higher than the industry’s average of 18.20X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MNST’s current and next year earnings implies a year-over-year rise of 22.8% and 15.2%, respectively.
Image Source: Zacks Investment Research
Top-Ranked Stocks to Consider
The Simply Good Foods Company (SMPL - Free Report) , a consumer-packaged food and beverage company, engages in the development, marketing, and sale of snacks and meal replacements, and other products in North America and internationally. SMPL currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Simply Good Foods' current fiscal-year sales implies a decline of 0.3%, and the same for current fiscal-year earnings implies growth of 1.6% from the year-ago reported figures. SMPL delivered a trailing four-quarter earnings surprise of 5.53%, on average.
Kimberly-Clark Corporation (KMB - Free Report) manufactures and markets personal care products in the United States. KMB currently carries a Zacks Rank #1.
The Zacks Consensus Estimate for Kimberly-Clark's current fiscal-year sales and earnings implies a decline of 2.1% and 6.2%, respectively, from the year-ago actuals. KMB delivered a trailing four-quarter earnings surprise of 18.9%, on average.
Medifast, Inc. (MED - Free Report) operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. MED currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for Medifast's current fiscal-year sales and earnings implies a decline of 36.7% and 156.5%, respectively, from the year-ago actuals. MED delivered a trailing four-quarter negative earnings surprise of 640%, on average.